AB
Allison Bratzel Piper Sandler Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
25
Avg Return
Past Year
Past Year
11%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past 3 Months
Positive
81.8%
Neutral
18.2%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
| Stock | Rating | Price Target |
Upside Downside |
Ratings 3 Months |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Overweight
Maintained
| $58 |
28%
upside
| 1 | +16% |
0
%
| 4 Mar ‘26 5 hours ago |
|
|
|
Overweight
Maintained
| $100 |
26%
upside
| 2 | +19% |
0
%
| 27 Feb ‘26 5 days ago |
|
|
|
Neutral
Maintained
| $38 |
34%
upside
| 1 | – |
–
| 6 Feb ‘26 26 days ago |
|
|
|
Overweight
Maintained
| $84 |
42%
upside
| 1 | +2.4% |
0
%
| 6 Feb ‘26 26 days ago |
|
|
|
Overweight
Maintained
| $110 |
12%
upside
| 1 | -1.7% |
0
%
| 6 Feb ‘26 26 days ago |
|
|
|
Overweight
Maintained
| $4 |
223%
upside
| 1 | -15% |
0
%
| 6 Feb ‘26 26 days ago |
|
|
|
Overweight
Maintained
| $14 |
93%
upside
| 1 | -9.8% |
0
%
| 5 Feb ‘26 27 days ago |
|
|
|
Overweight
Maintained
| $4 |
90%
upside
| 1 | +3% |
0
%
| 5 Feb ‘26 27 days ago |
|
|
|
Neutral
Downgraded
| $0.5000 |
48%
upside
| 1 | -64% |
0
%
| 26 Jan ‘26 1 month ago |
|
|
|
Overweight
Maintained
| $42 |
31%
upside
| 1 | +108% |
0
%
| 23 Jan ‘26 1 month ago |
|